400-8-075
50.68
[]. D K Choi, et al. Prophylactic control of post-operative nausea and vomiting using ondansetron and ramosetron after cardiac surgery. Acta Anaesthesiol Scand. 00 Sep;54(8):96-9.
[]. Jung-Hee Ryu, et al. Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trial. Clin Ther. 0 Sep;(9):6-7.
[]. Jung-Hee Ryu, et al. Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: prospective, randomized, and double-blind study. Int J Surg. 0;():8-7.
[4]. K J Lee, et al. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine. Neurogastroenterol Motil. 0 Dec;():098-04.
[5]. Pere Clavé, et al. Treatment of IBS-D with 5-HT receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets. Neurogastroenterol Motil. 0 Dec;():05-5.
H0
P64-P70-P0-P50
沪ICP备709645号
